作者: Richard K. Burt
DOI: 10.1007/978-1-4615-6349-5_14
关键词:
摘要: Patients afflicted by an autoimmune disorder have generally been considered to a normal life expectancy complicated relapsing/remitting or chronic disease. However, depending upon the disease, there may exist subset of affected individuals who shorter survival than general population. It is this high-risk group with early mortality for whom Marmont coined term SADS, severe diseases [1].